FDA approves first human trial for Paradromics' brain-computer interface that could restore speech for paralyzed patients ...

Using a Neuralink brain implant, a man who is quadriplegic can once again play video games like "Battlefield 6." ...

The Cybathlon sees teams of researchers and technology ‘pilots’ compete to see whose brain-computer interface holds the most ...

US brain-computer-interface startup Paradromics is quickly establishing itself as a major player in the neural-device space, ...

The ability of these devices to access aspects of a person’s innermost life, including preconscious thought, raises the ...

Paradromics Inc., a neurotechnology company developing the highest data-rate brain-computer interface (BCI) platform, today announced the US FDA has granted Investigational Device Exemption (IDE) ...

The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.

Neural Speech Inc. aims to provide a link to the outside world for people who are unable to communicate, Philip Kennedy, ...

A Penn case study finds that a brain-computer interface shows the medication produces only short-term or incomplete effects on related brain activity in a patient with obesity, highlighting the need ...

Synchron successfully implanted the first FDA-approved brain-computer interface in a U.S. patient with ALS. The device enables paralyzed individuals to communicate and control devices using brain ...

Neurotechnology company Paradromics will test its device in a trial aimed at safely restoring speech for people with severe motor impairments.

Scientists have developed better devices to help people with disabilities regain function. These findings will be presented at Neuroscience 2025, the annual meeting of the Society for Neuroscience and ...